내강 봉합 디바이스 시장 기회, 성장요인, 업계 동향 분석 및 예측(2026-2035년)

The Global Endoluminal Suturing Devices Market was valued at USD 81.1 million in 2025 and is estimated to grow at a CAGR of 14.1% to reach USD 290.9 million by 2035.

Rising demand for minimally invasive treatment procedures and the increasing incidence of chronic health conditions worldwide are major factors contributing to market expansion. Endoluminal suturing devices are advanced medical instruments developed to place sutures during endoscopic procedures performed through internal luminal pathways. These systems are widely utilized for tissue closure, repair, and fixation during gastrointestinal interventions, including bariatric procedures and treatments associated with digestive disorders. Growing preference for minimally invasive care among aging populations is further supporting market growth, as older adults are increasingly affected by obesity-related complications and gastrointestinal conditions that require advanced therapeutic procedures. Continuous innovation in device technology has improved tissue capture systems, full-thickness suturing performance, and compatibility with standard endoscopic platforms. These advancements have broadened the use of endoluminal suturing systems across multiple clinical applications, including defect management, hemostatic procedures, tissue approximation, and fixation procedures, while reducing the need for conventional open surgeries.

The single-use segment accounted for 53.7% share in 2025 due to increasing emphasis on patient safety, infection prevention, and standardized clinical performance. Disposable endoluminal suturing devices have become widely preferred because they help eliminate contamination risks and reduce the complexity associated with sterilization procedures. Healthcare providers are increasingly adopting these products to maintain consistent treatment quality during therapeutic endoscopic procedures. Rising awareness regarding hygiene-focused healthcare practices and stricter compliance standards has further accelerated the adoption of single-use devices across hospitals and specialty care centers.

The hospitals segment generated USD 48 million in 2025, making it the leading end-use category in the market. Hospitals continue to represent the primary setting for advanced gastrointestinal, bariatric, and therapeutic endoscopic procedures that require endoluminal suturing systems. The availability of technologically advanced endoscopy suites, highly trained multidisciplinary teams, and access to specialized patient care has strengthened product utilization across hospital environments. Increasing focus on minimally invasive treatment approaches and improved procedural efficiency has also contributed to the widespread integration of these devices into clinical workflows.

North America Endoluminal Suturing Devices Market accounted for 36.3% share in 2025. The regional market is being driven by the growing prevalence of obesity and gastrointestinal disorders, which continue to increase the demand for minimally invasive bariatric and therapeutic procedures. Strong healthcare infrastructure, rapid adoption of advanced endoscopic technologies, and the presence of experienced medical professionals have further supported market development across the region. Healthcare providers are increasingly prioritizing technologies that improve patient recovery, shorten hospital stays, and enhance treatment outcomes, which continues to strengthen demand for endoluminal suturing systems throughout North America.

Key companies operating in the Endoluminal Suturing Devices Market include Medtronic, Teleflex, Karl Storz, Ovesco, Olympus, Endo Tools Therapeutics, B. Braun, Boston Scientific, Terumo, RICHARD WOLF, Cook Group, ergosuture, LUMENDi, Johnson & Johnson, and USGI MEDICAL. Companies participating in the endoluminal suturing devices market are focusing heavily on technological innovation, strategic collaborations, and product portfolio expansion to strengthen their market position. Manufacturers are investing in advanced suturing platforms with improved tissue handling, enhanced precision, and compatibility with modern endoscopic systems to support complex minimally invasive procedures. Many companies are also expanding their presence through partnerships with hospitals, gastroenterology centers, and healthcare distributors to improve product accessibility across developed and emerging markets. In addition, businesses are emphasizing regulatory approvals, clinician training programs, and research initiatives to improve adoption rates and strengthen brand credibility. Market participants are further concentrating on single-use device development, workflow optimization, and integration with advanced endoscopic technologies to improve procedural efficiency and enhance patient outcomes across healthcare facilities.

Table of Contents

Chapter 1 Research Methodology

• 1.1 Research approach
• 1.2 Quality commitments
  • 1.2.1 GMI AI policy & data integrity commitment
    • 1.2.1.1 Source consistency protocol
• 1.3 Research trail & confidence scoring
  • 1.3.1 Research trail components
  • 1.3.2 Scoring components
• 1.4 Data collection
  • 1.4.1 Partial list of primary sources
• 1.5 Data mining sources
  • 1.5.1 Paid sources
    • 1.5.1.1 Sources, by region
• 1.6 Base estimates and calculations
  • 1.6.1 Base year calculation
• 1.7 Forecast model
  • 1.7.1 Quantified market impact analysis
    • 1.7.1.1 Mathematical impact of growth parameters on forecast
• 1.8 Research transparency addendum
  • 1.8.1 Source attribution framework
  • 1.8.2 Quality assurance metrics
  • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Product type trends
  • 2.2.3 Application trends
  • 2.2.4 End use trends
• 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of chronic disease across the globe
    • 3.2.1.2 Increasing demand for minimally invasive procedures
    • 3.2.1.3 Technological advancements
    • 3.2.1.4 Rising geriatric population
    • 3.2.1.5 Rising demand for outpatient and same-day surgical care
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Stringent regulatory scenario
    • 3.2.2.2 Dearth of skilled healthcare professionals
  • 3.2.3 Opportunities
    • 3.2.3.1 Integration of robotic platforms to simplify procedural workflows
    • 3.2.3.2 Development of portable systems tailored for ambulatory surgical centers (ASCs)
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Pricing trend analysis
• 3.6 Technology and innovation landscape (Driven by Primary Research)
  • 3.6.1 Current technological trends
  • 3.6.2 Emerging technologies
• 3.7 Future market trends (Driven by Primary Research)
• 3.8 Patent analysis
• 3.9 Impact of AI & Generative AI on the Market (Driven by Primary Research)
• 3.10 Porter's analysis
• 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis (Driven by Primary Research)
  • 4.3.1 Global
  • 4.3.2 North America
  • 4.3.3 Europe
  • 4.3.4 Asia Pacific
  • 4.3.5 LAMEA
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Single use
• 5.3 Reusable

Chapter 6 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Gastrointestinal defects
• 6.3 Bariatric surgery
• 6.4 Gastroesophageal reflux disease (GERD)
• 6.5 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgical centers
• 7.4 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 MEA
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 B. Braun
• 9.2 Boston Scientific
• 9.3 Cook Group
• 9.4 Endo Tools Therapeutics
• 9.5 ergosuture
• 9.6 Johnson & Johnson
• 9.7 Karl Storz
• 9.8 LUMENDi
• 9.9 Medtronic
• 9.10 OLYMPUS
• 9.11 Ovesco
• 9.12 RICHARD WOLF
• 9.13 Teleflex
• 9.14 Terumo
• 9.15 USGI MEDICAL